An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers

Sponsor
Wayne State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06054412
Collaborator
(none)
20
1
28

Study Details

Study Description

Brief Summary

The proposed study will collect novel data evaluating the feasibility of the NFB training program delivered in an outpatient mental health setting and its influence on mothers' overall sense of well-being, and further investigate whether enhanced well-being is associated with positive changes in emotion regulation capacities, trauma-related mental health symptoms, parenting behaviors and attitudes, and infant behavioral outcomes (i.e., crying, fussing) among postpartum mothers with a history of childhood trauma and clinically concerning trauma-related mental health symptoms.

Condition or Disease Intervention/Treatment Phase
  • Device: Neuroptimal (Zengar, Inc.) Neurofeedback
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility of an Adjunctive Dynamic Neurofeedback Training Program to Enhance Wellness Among Postpartum Mothers With a History of Trauma Exposure
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Mar 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Other: Neurofeedback Training

Mothers in the Neurofeedback Training group will complete pre and post-training self-report surveys assessing trauma symptoms, mental health, parenting attitudes and behaviors, and infant crying patterns and socioemotional development. Mothers in this group will all be receiving in-person psychotherapy outside of the study, and they will all demonstrate clinically significant symptoms aligned with post-traumatic stress disorder and/or it's dissociative subtype.

Device: Neuroptimal (Zengar, Inc.) Neurofeedback
Mothers in the Neurofeedback Training group will complete one training session (lasting approximately 33 minutes) a week for a total of 12 weeks, using the Neuroptimal (Zengar, Inc.) neurofeedback device.

Outcome Measures

Primary Outcome Measures

  1. Neuro-QoL Item Bank v1.0 - Positive Affect and Well-Being - Short Form [Weekly, throughout the course of the 3-month training phase]

    To measure maternal well-being. Minimum score = 9 Maximum score = 45 Higher scores mean a better outcome.

  2. Post-Traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fith Edition (PTSD Checklist for DSM-5 - Standard) [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure maternal symptoms of PTSD Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

  3. Dissociative Experiences Scale II [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To assess maternal symptoms of dissociation. Minimum score = 0 Maximum score = 100 Higher scores mean a worse outcome.

  4. Patient Health Questionnaire 8 [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure maternal depressive symptoms. Minimum score = 0 Maximum score = 24 Higher scores mean a worse outcome.

  5. The State Trait Anger Expression Inventory [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure maternal anger control. Minimum score = 10 Maximum score = 40 Higher scores mean a worse outcome.

  6. Brief Child Abuse Potential screener, an abbreviated version of the Child Abuse Potential Inventory ([CAP]), © 1980, 1986, Joel S. Milner, PhD.) [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    The Brief Child Abuse Potential is a screening tool that is an abbreviated version of the Child Abuse Potential Inventory ([CAP]), © 1980, 1986, Joel S. Milner, PhD.). This measure is used to understand a caregiver's potential risk of perpetrating acts of child abuse. The measure includes 33 items; caregiver's endorse whether they "Agree" or "Disagree" with each item. Agree responses are given a score of 1, Disagree responses are given a score of 0. Minimum score = 0 Maximum score = 33 Higher scores mean a worse outcome.

  7. Parenting Stress Index [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure stress associated with parenting. Minimum score = 36 Maximum score = 180 Higher scores mean a better outcome.

  8. Parenting Sense of Competence scale [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure feelings of parental competency and self-efficacy. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

  9. The Crying Patterns Questionnaire [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure infant crying and fussing patterns. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

  10. The Baby Pediatric Symptom Checklist of the Survey of Well-Being for Young Children [The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.]

    To measure infant psychosocial wellbeing. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

  11. Neuro-QoL Item Bank v1.0 - Emotional and Behavioral Dyscontrol - Short Form [Weekly, throughout the course of the 3-month intervention]

    To measure maternal emotional and behavioral self-regulation. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must have clinically concerning symptoms of Post-traumatic Stress Disorder and/or it's dissociative sub-type, as indicated by either a score of 3+ on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) screening measure for PTSD symptoms OR endorsement of 2 or more past-month symptoms of moderate or greater severity on the depersonalization/derealization subscale of the Dissociative Subtype of PTSD Scale (DSPS).

  • Must be between 3-24 months postpartum

  • Must be receiving regular, primarily in-person psychotherapy from a therapist at a clinic in the Greater Detroit area.

Exclusion Criteria:
  • Are currently pregnant

  • Have a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or substance use disorder) or neurological or pervasive developmental disorder

  • Have a documented history of epilepsy

  • Have ever experienced previous head injury with loss of consciousness

  • Are currently experiencing domestic or intimate partner violence or otherwise state that their current living conditions are unsafe

  • Are currently experiencing psychosis or have been suicidal within the last six months

  • Are currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis

  • Have engaged in self-harming behaviors in the last 3 months requiring medical attention

  • Do not have competence to understand or consent to the study procedures

  • Do not have fluency in written and spoken English

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Wayne State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lisa S. Panisch, PhD, MSW, Assistant Professor, Wayne State University
ClinicalTrials.gov Identifier:
NCT06054412
Other Study ID Numbers:
  • IRB-23-02-5477
First Posted:
Sep 26, 2023
Last Update Posted:
Sep 26, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 26, 2023